
- Telehealth visits
- Insurance plan information

Diane Ehrensaft, PhD
Psychology (Child and Adolescent Psychology)Mental Health Director, Child and Adolescent Gender Center- Telehealth visits
- Insurance plan information



Diane Ehrensaft, PhD
Psychology (Child and Adolescent Psychology)Mental Health Director, Child and Adolescent Gender Center- Telehealth visits
- Insurance plan information
On this page
About me
Diane Ehrensaft is a developmental and clinical psychologist who cares for children, adolescents, young adults and families. She specializes in gender-affirmative care for transgender and gender-expansive patients; assessment and psychotherapy for children; and support for parents and children in families created through assisted reproductive technology.
Ehrensaft earned a doctorate in psychology from the University of Michigan.
Ehrensaft's research focuses on the development and psychological experiences of transgender, gender-nonbinary, gender-expansive or gender-exploring children and adolescents. She is involved in studies of the developmental pathways of gender-expansive children before they reach puberty and mental health outcomes for youths who choose puberty blockers or gender-affirming hormones as part of their pediatric gender care.
Ehrensaft is the author of two books, The Gender Creative Child: Pathways for Nurturing and Supporting Children Who Live Outside Gender Boxes and Gender Born, Gender Made: Raising Healthy Gender-Nonconforming Children.
Education & training
Residency
- Psychology, Childrens Hospital of San Francisco - GME
- Psychology, Childrens Hospital and Medical Center - GME
Degree
- PHD, University of Michigan
Academic Title
- Adjunct Professor
My expertise
Specialties
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
